Skip to content
Altius – Lifestyle
Author:
Faron Pharmaceuticals
Faron Pharmaceuticals Receives Decision from Nasdaq Helsinki Disciplinary Committee
June 5, 2026
Faron Pharmaceuticals Ltd: Holding(s) In Company
June 4, 2026
Faron Pharmaceuticals LTD: Holding(s) in Company
June 1, 2026
Faron Pharmaceuticals Ltd: Special Rights attached to the First and Second Tranche of Bonds
May 28, 2026
Faron Pharmaceuticals LTD: Holding(S) In Company
May 28, 2026
Faron Pharmaceuticals LTD: Holding(s) In Company
May 18, 2026
Faron to Present New BEXMAB Translational and Clinical Data in HR-MDS at EHA 2026
May 13, 2026
Faron Pharmaceuticals Ltd: Termination of Liquidity Provision Service
May 6, 2026
Faron Pharmaceuticals Ltd: Holding(S) In Company
May 5, 2026
Faron Pharmaceuticals Ltd: Directorate Appointment
May 5, 2026
1
2
3
Next Page
→